Therefore, in this report we aimed to evaluate the association between common SNPs in the OPN (also known as SPP1) and CD44 genes and three survival endpoints, as well as the potential relationship with circulating OPN levels before treatment, in patients with inoperable NSCLC receiving radiotherapy (RT) alone or in combination with chemotherapy (CTRT). This evidence concerns the gene CD44 and non-small cell lung carcinoma.